The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 4 , Pages 918-925 , April 2010

Experimental investigation of direct myocardial protective effect of atrial natriuretic peptide in cardiac surgery

  • Shinji Wakui, MD

      Affiliations

    • Advanced Research Institute for the Sciences and Humanity (ARISH), Nihon University, Tokyo, Japan
    • Department of Cardiovascular Surgery, Nihon University, Tokyo, Japan
    • Department of Thoracic and Cardiovascular Surgery, Heart Center North-Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany
    • Corresponding Author InformationAddress for reprints: Shinji Wakui, MD, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstraße 11, 32545 Bad Oeynhausen, Germany.
    • ,
  • Akira Sezai, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Nihon University, Tokyo, Japan
    • ,
  • Gero Tenderich, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart Center North-Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany
    • ,
  • Mitsumasa Hata, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Nihon University, Tokyo, Japan
    • ,
  • Syunji Osaka

      Affiliations

    • Department of Cardiovascular Surgery, Nihon University, Tokyo, Japan
    • ,
  • Yoshiki Taniguchi

      Affiliations

    • Department of Collaboration, Nihon University, Tokyo, Japan
    • ,
  • Reiner Koerfer, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart Center North-Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany
    • ,
  • Kazutomo Minami, MD, PhD

      Affiliations

    • Advanced Research Institute for the Sciences and Humanity (ARISH), Nihon University, Tokyo, Japan
    • Department of Cardiovascular Surgery, Nihon University, Tokyo, Japan
    • Department of Thoracic and Cardiovascular Surgery, Heart Center North-Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany

Received 23 November 2008 ,Revised 26 July 2009 ,Accepted 9 August 2009.

References 

  1. Kanagawa K, Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide. Biochem Biophys Res Commun. 1984;118:131–139
  2. Maack T, Marion DN, Camargo MJ, Kleinert HD, Laragh JH, Vaughan ED, et al. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function and the renin-aldosterone system in dogs. Am J Med. 1984;77:1069–1075
  3. Ishihara T, Aisaka K, Hattori Y, Hamasaki S, Morita M, Noguchi T, et al. Vasodilatory and diuretic actions of α-human atrial natriuretic polypeptide (α-hANP). Life Sci. 1985;36:1205–1215
  4. Weder AB, Sekkarie MA, Takiyyuddin M, Schork NJ, Julius S. Antihypertensive and hypotensive effects of atrial natriuretic factor in men. Hypertension. 1987;10:582–589
  5. Wedel B, Garbers D. The guanylyl cyclase family at Y2K. Annu Rev Physiol. 2001;63:215–233
  6. Venugopal J. Cardiac natriuretic peptides—hope or hype?. J Clin Pharm Ther. 2001;26:15–31
  7. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation. 2003;107:807–810
  8. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation. 2001;103:72–77
  9. Kishimoto I, Rossi K, Garbers DL. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci U S A. 2001;98:2703–2706
  10. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, et al. Guanylyl cyclase-A inhibits angiotensin type 1A receptor–mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation. 2002;106:1722–1728
  11. Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, et al. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice atrial and brain natriuretic peptides. Circulation. 2005;111:3095–3104
  12. Sezai A, Shiono M, Orime Y, Hata H, Hata M, Negishi N, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg. 2000;69:732–738
  13. Sezai A, Hata M, Wakui S, Shiono M, Negishi N, Kasamaki Y, et al. Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: possibility of postoperative left ventricular remodeling effect. Circ J. 2006;70:1426–1431
  14. Sezai A, Hata M, Wakui S, Niino T, Takayama T, Hirayama A, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J. 2007;71:1401–1407
  15. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985;313:1330–1340
  16. Stein BC, Levin RI. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J. 1998;135:914–923
  17. Kuga H, Ogawa K, Oida A, Taguchi I, Nakatsugawa M, Hoshi T, et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J. 2003;67:443–448
  18. Wakui S. Experimental study on myocardial protection by adjunct use of carperitide (hANP)in cardiac surgery. Ann Thorac Cardiovasc Surg. 2005;11:12–20
  19. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al. Human atrial natriuretic peptide and nicorandil as an adjunct to reperfusion therapy for acute myocardial infarction with ST-segment elevation: the randomised J-WIND (Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage) trials. Lancet. 2007;370:1483–1493
  20. Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP, Pike MM. Quantification of [Ca2+] in perfused hearts: critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res. 1990;66:1255–1267
  21. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A. 1984;81:7661–7664
  22. Munzel T, Feil R, Mulsch A, Lohmann SM, Hormann F, Walter U. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate–dependent protein kinase. Circulation. 2003;108:2172–2183
  23. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg. 1999;68:1898–1904

 Disclosures: None.

PII: S0022-5223(09)01082-4

doi: 10.1016/j.jtcvs.2009.08.030

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 4 , Pages 918-925 , April 2010

Article Tools

* Image Usage & Resolution